Jafron Biomedical Co.,Ltd. (China)

Jafron Biomedical Co., Ltd., located in Zhuhai, is a global provider of technology, product, and therapy services in the hemoadsorption industry. Established in 1989, the company has a market value of $7 billion and operates three branches, 11 subsidiaries, one sub-subsidiary, and medical foundation, insurance, etc. Jafron specializes in the research and development, production, and sales of blood purification products primarily in the hemoadsorption field. Their products and services cater to patients worldwide, addressing various conditions such as ESRD diseases, acute poisoning, critical illness, hepatopathy, immunological disorders, etc. The company has a strong presence with 183 offices in China and five global service centers in Vietnam, Europe, South America, etc. They have a dedicated team of over 1,100 staff and 1,000 partners who provide professional therapy services. Jafron's flagship product, the "HA series disposable hemoperfusion cartridge," developed by the company, is widely used in more than 8,000 key hospitals across 80 countries and regions, with 5 million cases of clinical application annually. As a global adsorption therapies provider, Jafron is actively involved in all aspects of disease solutions, from research and development to manufacturing their hemoadsorption products, and offering comprehensive therapy options. The company is committed to exploring novel medical fields to save lives, improve patients' quality of life, and contribute to a better world through health technology.